Nephrol Dial Transplant (2000) 15: 23-27
© 2000 European Renal Association-European Dialysis and Transplant Association
Primary renal vasculitis in Norfolk—increasing incidence or increasing recognition?
1 Department of Rheumatology, 2 Department of Nephrology, Norfolk and Norwich Healthcare NHS Trust, Norwich and 3 Ipswich Hospital NHS Trust, Ipswich, UK
Correspondence and offprint requests to: Dr S. E. Lane, Department of Rheumatology, Norfolk and Norwich Healthcare NHS Trust, Brunswick Rd, Norwich, NR1 3SR, UK.
Background. The incidence of renal vasculitis has previously been estimated using histological definitions or only a single clinical diagnosis, e.g. Wegener's Granulomatosis (WG). Our hospital is the single referral centre for the former Norwich Health Authority (NHA) which encompasses a stable, homogenous, well-defined and studied population. We estimated the overall incidence of primary renal vasculitis and the incidence within individual clinical disease classifications.
Methods. All cases of primary renal vasculitis diagnosed within the NHA over 66 months (1992–1997) were identified by review of renal biopsies, the Norfolk Vasculitis Register, hospital discharge summaries and plasmapheresis records. Patients were classified using the 1990 American College of Rheumatology criteria for Polyarteritis Nodosa (PAN), Churg Strauss Syndrome (CSS) and Henoch–Schonlein Purpura; the Chapel Hill Consensus Conference Definitions for Microscopic Polyangiitis (mPA) and the Lanham criteria for CSS. Incidence figures were calculated using the NHA adult population of 413747 (1994). Ninety-five per cent confidence intervals (C.I.) were calculated using the poisson distribution.
Results. The overall annual incidence for primary renal vasculitis was 18/million (C.I. 12.9–24.4). The annual incidence of renal involvement of individual diseases was as follows: WG 7.9/million (95% C.I. 4.7–12.5); mPA 7.5/million (95% C.I. 4.4–12.0); PAN 7.0/million (95% C.I. 4.0–11.4); HSP 3.1/million (95% C.I. 1.2–6.3); CSS 1.3/million (95% C.I. 0.3–3.9).
Conclusions. The annual incidence for primary renal vasculitis overall and the individual subtypes in Norfolk is much higher than previous European estimates. This may reflect an increasing incidence in primary renal vasculitis with time or underestimation in previous studies. However the incidence of renal vasculitis in our population is markedly lower than reported in Kuwait. There may therefore be true variation in incidence between populations which could have implications for the aetiology of primary vasculitis.
Keywords: classification; epidemiology; pauci-immune glomerulonephritis; vasculitis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. A. Watts, D. G. I. Scott, D. R. W. Jayne, T. Ito-Ihara, E. Muso, S. Fujimoto, Y. Harabuchi, S. Kobayashi, K. Suzuki, and H. Hashimoto Renal vasculitis in Japan and the UK--are there differences in epidemiology and clinical phenotype? Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3928 - 3931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-J. Liu, M. Chen, F. Yu, M.-H. Zhao, and H.-Y. Wang Evaluation of a new algorithm in classification of systemic vasculitis Rheumatology, May 1, 2008; 47(5): 708 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A.F. de Lind van Wijngaarden, L. van Rijn, E. C. Hagen, R. A. Watts, G. Gregorini, J. W. C. Tervaert, A. D. Mahr, J. L. Niles, E. de Heer, J. A. Bruijn, et al. Hypotheses on the Etiology of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis: The Cause Is Hidden, but the Result Is Known Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 237 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. C. Macdougall, R. M. Temple, J. T. C. Kwan, and on behalf of the EPO-GBR-2 Study Group Is early treatment of anaemia with epoetin-{alpha} beneficial to pre-dialysis chronic kidney disease patients? Results of a multicentre, open-label, prospective, randomized, comparative group trial Nephrol. Dial. Transplant., March 1, 2007; 22(3): 784 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rossert, C. Gassmann-Mayer, D. Frei, and W. McClellan Prevalence and predictors of epoetin hyporesponsiveness in chronic kidney disease patients Nephrol. Dial. Transplant., March 1, 2007; 22(3): 794 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Roger and A. Levin Epoetin trials: randomised controlled trials don't always mimic observational data Nephrol. Dial. Transplant., March 1, 2007; 22(3): 684 - 686. [Full Text] [PDF]
|
|
|
|
|
|
S. Fujimoto, S. Uezono, S. Hisanaga, K. Fukudome, S. Kobayashi, K. Suzuki, H. Hashimoto, H. Nakao, and H. Nunoi Incidence of ANCA-Associated Primary Renal Vasculitis in the Miyazaki Prefecture: The First Population-Based, Retrospective, Epidemiologic Survey in Japan Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(5): 1016 - 1022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.E. Lane, R.A. Watts, L. Shepstone, and D.G.I. Scott Primary systemic vasculitis: clinical features and mortality QJM, February 1, 2005; 98(2): 97 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Rivera, J. M. Lopez-Gomez, and R. Perez-Garcia Frequency of renal pathology in Spain 1994-1999 Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1594 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Reinhold-Keller, K. Herlyn, R. Wagner-Bastmeyer, J. Gutfleisch, H. H. Peter, H. H. Raspe, and W. L. Gross No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register Rheumatology, May 1, 2002; 41(5): 540 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Briganti, J. Dowling, M. Finlay, P. A. Hill, C. L. Jones, P. S. Kincaid-Smith, R. Sinclair, J. J. McNeil, and R. C. Atkins The incidence of biopsy-proven glomerulonephritis in Australia Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1364 - 1367. [Abstract] [Full Text] [PDF]
|
|